PedAM

Pediatric Disease Annotations & Medicines


	transitional cell carcinoma

Disease ID	597
Disease	transitional cell carcinoma
Definition	A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Synonym	[m]transitional cell carcinoma nos [m]transitional cell carcinoma nos (morphologic abnormality) carcinoma cell transitional carcinoma transitional cell carcinoma, transitional cell carcinoma, transitional cell [disease/finding] carcinoma, urothelial, malignant carcinomas urothelial carcinomas, transitional cell cell carcinoma, transitional cell carcinomas, transitional tcc - transitional cell carcinoma transitional carcinoma transitional cell carcinoma (morphologic abnormality) transitional cell carcinoma, nos transitional cell carcinomas urothelial carcinoma
DOID	DOID:2671
UMLS	C0007138
MeSH	D002295
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:15) C0005684 \| bladder cancer \| 3 C0699885 \| bladder carcinoma \| 1 C0178879 \| urinary tract obstruction \| 1 C0007134 \| renal cell cancer \| 1 C0206681 \| clear cell carcinoma \| 1 C0002726 \| amyloidosis \| 1 C0023267 \| leiomyoma \| 1 C0024299 \| lymphoma \| 1 C0153687 \| skin metastasis \| 1 C0699790 \| colon carcinoma \| 1 C0000889 \| acanthosis nigricans \| 1 C0019829 \| hodgkin's lymphoma \| 1 C0153676 \| pulmonary metastases \| 1 C0398689 \| x-linked hyperimmunoglobulin m syndrome \| 1 C0740457 \| renal cancer \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:31) TNF \| 7124 \| CTD_human TP53 \| 7157 \| CTD_human PLAU \| 5328 \| CTD_human CCND1 \| 595 \| CTD_human GPX1 \| 2876 \| CTD_human PTGS2 \| 5743 \| CTD_human HRAS \| 3265 \| CTD_human CREBBP \| 1387 \| CTD_human CDKN1A \| 1026 \| CTD_human IFNA2 \| 3440 \| CTD_human NCOR1 \| 9611 \| CTD_human CSF3 \| 1440 \| CTD_human KMT2C \| 58508 \| CTD_human KMT2A \| 4297 \| CTD_human ARID1A \| 8289 \| CTD_human FGFR3 \| 2261 \| CTD_human GGH \| 8836 \| CTD_human ESPL1 \| 9700 \| CTD_human EP300 \| 2033 \| CTD_human KDM6A \| 7403 \| CTD_human ESR2 \| 2100 \| CTD_human PABPC1 \| 26986 \| CTD_human APAF1 \| 317 \| CTD_human VDR \| 7421 \| CTD_human CHD6 \| 84181 \| CTD_human TACC3 \| 10460 \| CTD_human DAPK1 \| 1612 \| CTD_human IGFBP3 \| 3486 \| CTD_human HRH2 \| 3274 \| CTD_human STAG2 \| 10735 \| CTD_human AMBP \| 259 \| CTD_human
Inferring Gene	(Waiting for update.)
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:266) 282706 \| DAOA-AS1 \| DISEASES 4830 \| NME1 \| DISEASES 1015 \| CDH17 \| DISEASES 340533 \| KIAA2022 \| DISEASES 3861 \| KRT14 \| DISEASES 54474 \| KRT20 \| DISEASES 6793 \| STK10 \| DISEASES 7380 \| UPK3A \| DISEASES 1113 \| CHGA \| DISEASES 81027 \| TUBB1 \| DISEASES 57136 \| APMAP \| DISEASES 7076 \| TIMP1 \| DISEASES 123876 \| ACSM2A \| DISEASES 4313 \| MMP2 \| DISEASES 10423 \| CDIPT \| DISEASES 7040 \| TGFB1 \| DISEASES 1048 \| CEACAM5 \| DISEASES 11045 \| UPK1A \| DISEASES 5054 \| SERPINE1 \| DISEASES 29760 \| BLNK \| DISEASES 1440 \| CSF3 \| DISEASES 3558 \| IL2 \| DISEASES 595 \| CCND1 \| DISEASES 1027 \| CDKN1B \| DISEASES 2597 \| GAPDH \| DISEASES 84519 \| ACRBP \| DISEASES 2026 \| ENO2 \| DISEASES 1611 \| DAP \| DISEASES 1839 \| HBEGF \| DISEASES 4292 \| MLH1 \| DISEASES 4436 \| MSH2 \| DISEASES 2956 \| MSH6 \| DISEASES 10459 \| MAD2L2 \| DISEASES 10352 \| WARS2 \| DISEASES 1509 \| CTSD \| DISEASES 2946 \| GSTM2 \| DISEASES 51426 \| POLK \| DISEASES 3223 \| HOXC6 \| DISEASES 1026 \| CDKN1A \| DISEASES 6659 \| SOX4 \| DISEASES 3860 \| KRT13 \| DISEASES 9787 \| DLGAP5 \| DISEASES 2952 \| GSTT1 \| DISEASES 968 \| CD68 \| DISEASES 1890 \| TYMP \| DISEASES 3852 \| KRT5 \| DISEASES 10343 \| PKDREJ \| DISEASES 3958 \| LGALS3 \| DISEASES 56163 \| RNF17 \| DISEASES 5920 \| RARRES3 \| DISEASES 2947 \| GSTM3 \| DISEASES 5156 \| PDGFRA \| DISEASES 80761 \| UPK3B \| DISEASES 9700 \| ESPL1 \| DISEASES 9038 \| TAAR5 \| DISEASES 3569 \| IL6 \| DISEASES 2995 \| GYPC \| DISEASES 999 \| CDH1 \| DISEASES 7077 \| TIMP2 \| DISEASES 7515 \| XRCC1 \| DISEASES 6855 \| SYP \| DISEASES 822 \| CAPG \| DISEASES 7379 \| UPK2 \| DISEASES 7348 \| UPK1B \| DISEASES 941 \| CD80 \| DISEASES 119 \| ADD2 \| DISEASES 2247 \| FGF2 \| DISEASES 3383 \| ICAM1 \| DISEASES 4171 \| MCM2 \| DISEASES 1950 \| EGF \| DISEASES 5423 \| POLB \| DISEASES 5243 \| ABCB1 \| DISEASES 11178 \| LZTS1 \| DISEASES 10180 \| RBM6 \| DISEASES 939 \| CD27 \| DISEASES 2065 \| ERBB3 \| DISEASES 5925 \| RB1 \| DISEASES 27132 \| CPNE7 \| DISEASES 7157 \| TP53 \| DISEASES 2064 \| ERBB2 \| DISEASES 134864 \| TAAR1 \| DISEASES 1956 \| EGFR \| DISEASES 1030 \| CDKN2B \| DISEASES 3439 \| IFNA1 \| DISEASES 4915 \| NTRK2 \| DISEASES 3145 \| HMBS \| DISEASES 4319 \| MMP10 \| DISEASES 7424 \| VEGFC \| DISEASES 10666 \| CD226 \| DISEASES 5458 \| POU4F2 \| DISEASES 6317 \| SERPINB3 \| DISEASES 84959 \| UBASH3B \| DISEASES 351 \| APP \| DISEASES 64798 \| DEPTOR \| DISEASES 10 \| NAT2 \| DISEASES 23420 \| NOMO1 \| DISEASES 3815 \| KIT \| DISEASES 3242 \| HPD \| DISEASES 267 \| AMFR \| DISEASES 126205 \| NLRP8 \| DISEASES 3856 \| KRT8 \| DISEASES 10630 \| PDPN \| DISEASES 2215 \| FCGR3B \| DISEASES 27306 \| HPGDS \| DISEASES 6259 \| RYK \| DISEASES 308 \| ANXA5 \| DISEASES 6690 \| SPINK1 \| DISEASES 134288 \| TMEM174 \| DISEASES 3562 \| IL3 \| DISEASES 1437 \| CSF2 \| DISEASES 220296 \| HEPACAM \| DISEASES 9317 \| PTER \| DISEASES 29123 \| ANKRD11 \| DISEASES 8000 \| PSCA \| DISEASES 21 \| ABCA3 \| DISEASES 956 \| ENTPD3 \| DISEASES 116285 \| ACSM1 \| DISEASES 5734 \| PTGER4 \| DISEASES 140738 \| TMEM37 \| DISEASES 171558 \| PTCRA \| DISEASES 729201 \| SPACA5B \| DISEASES 389852 \| SPACA5 \| DISEASES 3575 \| IL7R \| DISEASES 4493 \| MT1E \| DISEASES 5340 \| PLG \| DISEASES 7015 \| TERT \| DISEASES 3265 \| HRAS \| DISEASES 29127 \| RACGAP1 \| DISEASES 947 \| CD34 \| DISEASES 51172 \| NAGPA \| DISEASES 836 \| CASP3 \| DISEASES 2944 \| GSTM1 \| DISEASES 26986 \| PABPC1 \| DISEASES 354 \| KLK3 \| DISEASES 1442 \| CSH1 \| DISEASES 4684 \| NCAM1 \| DISEASES 8851 \| CDK5R1 \| DISEASES 58492 \| ZNF77 \| DISEASES 6817 \| SULT1A1 \| DISEASES 3039 \| HBA1 \| DISEASES 4312 \| MMP1 \| DISEASES 923 \| CD6 \| DISEASES 29946 \| SERTAD3 \| DISEASES 338322 \| NLRP10 \| DISEASES 3855 \| KRT7 \| DISEASES 4496 \| MT1H \| DISEASES 6900 \| CNTN2 \| DISEASES 7490 \| WT1 \| DISEASES 5727 \| PTCH1 \| DISEASES 682 \| BSG \| DISEASES 51339 \| DACT1 \| DISEASES 3091 \| HIF1A \| DISEASES 2246 \| FGF1 \| DISEASES 23583 \| SMUG1 \| DISEASES 5329 \| PLAUR \| DISEASES 2261 \| FGFR3 \| DISEASES 166824 \| RASSF6 \| DISEASES 7743 \| ZNF189 \| DISEASES 1508 \| CTSB \| DISEASES 2272 \| FHIT \| DISEASES 51393 \| TRPV2 \| DISEASES 2066 \| ERBB4 \| DISEASES 9536 \| PTGES \| DISEASES 149998 \| LIPI \| DISEASES 23215 \| PRRC2C \| DISEASES 3455 \| IFNAR2 \| DISEASES 5757 \| PTMA \| DISEASES 9232 \| PTTG1 \| DISEASES 119391 \| GSTO2 \| DISEASES 80142 \| PTGES2 \| DISEASES 22881 \| ANKRD6 \| DISEASES 11186 \| RASSF1 \| DISEASES 51161 \| C3orf18 \| DISEASES 9961 \| MVP \| DISEASES 29950 \| SERTAD1 \| DISEASES 1612 \| DAPK1 \| DISEASES 5079 \| PAX5 \| DISEASES 2526 \| FUT4 \| DISEASES 1995 \| ELAVL3 \| DISEASES 1786 \| DNMT1 \| DISEASES 1201 \| CLN3 \| DISEASES 51150 \| SDF4 \| DISEASES 7037 \| TFRC \| DISEASES 2475 \| MTOR \| DISEASES 5742 \| PTGS1 \| DISEASES 3880 \| KRT19 \| DISEASES 5788 \| PTPRC \| DISEASES 3075 \| CFH \| DISEASES 5743 \| PTGS2 \| DISEASES 2214 \| FCGR3A \| DISEASES 6283 \| S100A12 \| DISEASES 1755 \| DMBT1 \| DISEASES 8661 \| EIF3A \| DISEASES 9446 \| GSTO1 \| DISEASES 1647 \| GADD45A \| DISEASES 1791 \| DNTT \| DISEASES 3725 \| JUN \| DISEASES 1558 \| CYP2C8 \| DISEASES 55165 \| CEP55 \| DISEASES 6491 \| STIL \| DISEASES 5728 \| PTEN \| DISEASES 7422 \| VEGFA \| DISEASES 958 \| CD40 \| DISEASES 4318 \| MMP9 \| DISEASES 5328 \| PLAU \| DISEASES 84181 \| CHD6 \| DISEASES 8565 \| YARS \| DISEASES 10904 \| BLCAP \| DISEASES 2934 \| GSN \| DISEASES 714 \| C1QC \| DISEASES 367 \| AR \| DISEASES 778 \| CACNA1F \| DISEASES 3105 \| HLA-A \| DISEASES 29914 \| UBIAD1 \| DISEASES 7056 \| THBD \| DISEASES 4609 \| MYC \| DISEASES 768 \| CA9 \| DISEASES 164312 \| LRRN4 \| DISEASES 7905 \| REEP5 \| DISEASES 3440 \| IFNA2 \| DISEASES 283820 \| NOMO2 \| DISEASES 5268 \| SERPINB5 \| DISEASES 10232 \| MSLN \| DISEASES 3875 \| KRT18 \| DISEASES 146183 \| OTOA \| DISEASES 57634 \| EP400 \| DISEASES 3903 \| LAIR1 \| DISEASES 7187 \| TRAF3 \| DISEASES 1443 \| CSH2 \| DISEASES 4831 \| NME2 \| DISEASES 4926 \| NUMA1 \| DISEASES 3161 \| HMMR \| DISEASES 3885 \| KRT34 \| DISEASES 4501 \| MT1X \| DISEASES 174 \| AFP \| DISEASES 5744 \| PTHLH \| DISEASES 23072 \| HECW1 \| DISEASES 4357 \| MPST \| DISEASES 7913 \| DEK \| DISEASES 2950 \| GSTP1 \| DISEASES 408050 \| NOMO3 \| DISEASES 6345 \| SRL \| DISEASES 100463285 \| MTRNR2L4 \| DISEASES 27247 \| NFU1 \| DISEASES 6916 \| TBXAS1 \| DISEASES 4495 \| MT1G \| DISEASES 2086 \| ERV3-1 \| DISEASES 8671 \| SLC4A4 \| DISEASES 1029 \| CDKN2A \| DISEASES 960 \| CD44 \| DISEASES 7124 \| TNF \| DISEASES 9498 \| SLC4A8 \| DISEASES 5378 \| PMS1 \| DISEASES 3451 \| IFNA17 \| DISEASES 283987 \| HID1 \| DISEASES 6513 \| SLC2A1 \| DISEASES 4193 \| MDM2 \| DISEASES 139804 \| RBMXL3 \| DISEASES 10793 \| ZNF273 \| DISEASES 285782 \| CAGE1 \| DISEASES 4914 \| NTRK1 \| DISEASES 7694 \| ZNF135 \| DISEASES 27164 \| SALL3 \| DISEASES 317 \| APAF1 \| DISEASES 100506195 \| LARGE-AS1 \| DISEASES 6055 \| RNR4 \| DISEASES
Locus	(Waiting for update.)

Disease ID	597
Disease	transitional cell carcinoma
Integrated Phenotype	(Waiting for update.)
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:12) HP:0002664 \| Neoplasia \| 4 HP:0030731 \| Carcinoma \| 3 HP:0009725 \| Bladder neoplasm \| 3 HP:0000010 \| Frequent urinary tract infections \| 1 HP:0002665 \| Lymphoma \| 1 HP:0002862 \| Bladder carcinoma \| 1 HP:0011034 \| Amyloid disease \| 1 HP:0000787 \| Renal calculi \| 1 HP:0000956 \| Keratosis nigricans \| 1 HP:0000790 \| Hematuria \| 1 HP:0000071 \| Narrowing of the ureter \| 1 HP:0012189 \| Hodgkin disease \| 1

Disease ID	597
Disease	transitional cell carcinoma
Manually Symptom	UMLS \| Name(Total Manually Symptoms:31) C1881254 \| inverted papilloma C1335748 \| adenocarcinoma of the renal pelvis C1332560 \| leiomyoma of the urinary bladder C0850011 \| human papilloma virus C0745091 \| hypereosinophilia C0742965 \| eosinophilic cystitis C0699885 \| carcinoma of the urinary bladder C0684830 \| axillary metastasis C0494165 \| liver metastases C0347016 \| spinal cord metastasis C0267361 \| pyeloduodenal fistula C0238457 \| renal vein thrombosis C0153687 \| skin metastasis C0153687 \| cutaneous metastasis C0153676 \| pulmonary metastasis C0153676 \| pulmonary metastases C0153676 \| lung metastases C0041960 \| ureterocele C0023501 \| leukemoid reaction C0022679 \| cystic kidneys C0022661 \| end stage renal disease C0022658 \| nephropathy C0021841 \| intestinal tumor C0020758 \| ichthyosis C0020437 \| hypercalcemia C0020295 \| hydronephrosis C0008497 \| choriocarcinoma C0005695 \| tumor of the bladder C0005695 \| bladder tumor C0002880 \| autoimmune haemolytic anaemia C0002793 \| anaplasia
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:4) C0023501 \| leukemoid reaction \| 1 C0153687 \| cutaneous metastasis \| 1 C0153676 \| pulmonary metastases \| 1 C0153687 \| skin metastasis \| 1

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:12)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs13181	25018058	2068	ERCC2	umls:C0007138	BeFree	The aim of this study was to examine the association between polymorphisms of the DNA repair genes, XRCC1 Arg194Trp, XRCC1 Arg399Gln, XRCC3 Thr241Met, and XPD Lys751Gln, with urinary arsenic profiles and UC.	0.002909916	2014	ERCC2;KLC3	19	45351661	T	A,G
rs13181	25018058	2068	ERCC2	umls:C2145472	BeFree	The aim of this study was to examine the association between polymorphisms of the DNA repair genes, XRCC1 Arg194Trp, XRCC1 Arg399Gln, XRCC3 Thr241Met, and XPD Lys751Gln, with urinary arsenic profiles and UC.	0.000542884	2014	ERCC2;KLC3	19	45351661	T	A,G
rs1799782	25018058	7515	XRCC1	umls:C0007138	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.00554839	2014	XRCC1	19	43553422	G	A
rs1799782	25018058	7515	XRCC1	umls:C2145472	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.000542884	2014	XRCC1	19	43553422	G	A
rs25487	25018058	7515	XRCC1	umls:C0007138	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.00554839	2014	XRCC1	19	43551574	T	C
rs25487	25018058	7515	XRCC1	umls:C2145472	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.000542884	2014	XRCC1	19	43551574	T	C
rs386493716	25018058	7515	XRCC1	umls:C0007138	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.00554839	2014	NA	NA	NA	NA	NA
rs386493716	25018058	7515	XRCC1	umls:C2145472	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.000542884	2014	NA	NA	NA	NA	NA
rs386545546	25018058	7515	XRCC1	umls:C0007138	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.00554839	2014	NA	NA	NA	NA	NA
rs386545546	25018058	7515	XRCC1	umls:C2145472	BeFree	XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.	0.000542884	2014	NA	NA	NA	NA	NA
rs7121	15824158	2778	GNAS	umls:C0007138	BeFree	To assess the role of the GNAS1 locus encoding G(alpha)s as a genetic factor for disease progression of transitional cell carcinoma (TCC) of the bladder, we genotyped the synonymous T393C polymorphism in 254 patients with TCC (minor allele frequency: 0.43) to examine a potential association between genotypes and disease progression.	0.000271442	2005	GNAS	20	58903752	C	T
rs9904341	19038421	332	BIRC5	umls:C0007138	BeFree	Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.	0.002638474	2009	BIRC5	17	78214286	G	C

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)

Mapped by lexical matching(Total Items:0)
(Waiting for update.)

Mapped by homologous gene(Total Items:0)
(Waiting for update.)

Chemical(Total Drugs:26)
CUI	ChemicalName	ChemicalID	CasRN	DiseaseName	DiseaseID	DirectEvidence	PubMedIDs
C0007138	allopurinol	D000493	315-30-0	carcinoma, transitional cell	MESH:D002295	marker/mechanism	1268818
C0007138	amiloride	D000584	2609-46-3	carcinoma, transitional cell	MESH:D002295	therapeutic	14644129
C0007138	baclofen	D001418	1134-47-0	carcinoma, transitional cell	MESH:D002295	marker/mechanism	17924939
C0007138	bortezomib	D000069286	-	carcinoma, transitional cell	MESH:D002295	therapeutic	17172406
C0007138	caffeine	D002110	1958/8/2	carcinoma, transitional cell	MESH:D002295	marker/mechanism	4638853
C0007138	chlorambucil	D002699	305-03-3	carcinoma, transitional cell	MESH:D002295	marker/mechanism	1949449
C0007138	ciprofloxacin	D002939	85721-33-1	carcinoma, transitional cell	MESH:D002295	therapeutic	10741713
C0007138	codeine	D003061	76-57-3	carcinoma, transitional cell	MESH:D002295	marker/mechanism	4638853
C0007138	cyclophosphamide	D003520	50-18-0	carcinoma, transitional cell	MESH:D002295	marker/mechanism	10806575
C0007138	cyclophosphamide	D003520	50-18-0	carcinoma, transitional cell	MESH:D002295	therapeutic	2993671
C0007138	cisplatin	D002945	15663-27-1	carcinoma, transitional cell	MESH:D002295	therapeutic	11104554
C0007138	gefitinib	C419708	184475-35-2	carcinoma, transitional cell	MESH:D002295	therapeutic	16813948
C0007138	gemcitabine	C056507	103882-84-4	carcinoma, transitional cell	MESH:D002295	therapeutic	11113764
C0007138	ifosfamide	D007069	3778-73-2	carcinoma, transitional cell	MESH:D002295	therapeutic	12425514
C0007138	mesna	D015080	19767-45-4	carcinoma, transitional cell	MESH:D002295	therapeutic	12425514
C0007138	methotrexate	D008727	1959/5/2	carcinoma, transitional cell	MESH:D002295	marker/mechanism	7909881
C0007138	methotrexate	D008727	1959/5/2	carcinoma, transitional cell	MESH:D002295	therapeutic	15518130
C0007138	mitomycin	D016685	1950/7/7	carcinoma, transitional cell	MESH:D002295	therapeutic	10071561
C0007138	mitoxantrone	D008942	65271-80-9	carcinoma, transitional cell	MESH:D002295	therapeutic	18510180
C0007138	paclitaxel	D017239	-	carcinoma, transitional cell	MESH:D002295	therapeutic	11104554
C0007138	romidepsin	C087123	-	carcinoma, transitional cell	MESH:D002295	therapeutic	17230511
C0007138	thiotepa	D013852	52-24-4	carcinoma, transitional cell	MESH:D002295	therapeutic	806708
C0007138	vinblastine	D014747	865-21-4	carcinoma, transitional cell	MESH:D002295	marker/mechanism	1949449
C0007138	vinblastine	D014747	865-21-4	carcinoma, transitional cell	MESH:D002295	therapeutic	11104554
C0007138	vincristine	D014750	-	carcinoma, transitional cell	MESH:D002295	marker/mechanism	8602639
C0007138	vindesine	D014751	53643-48-4	carcinoma, transitional cell	MESH:D002295	marker/mechanism	8602639

FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)

FDA labeling changes(Total Drugs:0)
(Waiting for update.)